| Feature Type | Standardized | Nominal ANOVA | ||||
|---|---|---|---|---|---|---|
| mRNA | Doxorubicin | gCSI | pan-cancer | AAC | -0.18 | 0.0002 |
| mRNA | LRRK2-IN-1 | CTRPv2 | pan-cancer | AAC | 0.12 | 0.002 |
| mRNA | tacedinaline | CTRPv2 | pan-cancer | AAC | 0.11 | 0.003 |
| mRNA | Mitomycin-C | GDSC1000 | pan-cancer | AAC | 0.1 | 0.004 |
| mRNA | lovastatin | CTRPv2 | pan-cancer | AAC | -0.1 | 0.006 |
| mRNA | Methotrexate | GDSC1000 | pan-cancer | AAC | 0.081 | 0.007 |
| mRNA | BYL-719 | CTRPv2 | pan-cancer | AAC | 0.12 | 0.007 |
| mRNA | BRD-K58730230 | CTRPv2 | pan-cancer | AAC | 0.2 | 0.007 |
| mRNA | Gemcitabine | gCSI | pan-cancer | AAC | -0.14 | 0.008 |
| mRNA | BRD-K16130065 | CTRPv2 | pan-cancer | AAC | 0.19 | 0.009 |